The documentary special "Living Proof," produced by Sheryl Lee Ralph, will premiere on Hulu on Dec. 1 in honor of World AIDS ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

The Bay Area Reporter reports that Delta Air Lines isn’t covering long-acting injectable PrEP, or the oral PrEP drug Descovy, ...

Medicaid provides health coverage for disabled and low-income populations, and the ACA expansion gives states the option to extend coverage to adults with up to 138% of the federal poverty line.

About 1,000 doses of Gilead Sciences Inc's drug lenacapavir were delivered to Zambia and Eswatini last Thursday, U.S. and ...

The United States, whose deep cuts to foreign aid this year under President Trump have severely impacted Africa’s health ...

It's a balmy afternoon in Mtubatuba, in northern KwaZulu-Natal (KZN), and the local taxi rank is abuzz with activity. Drivers are calling out their routes while others rev their engines, getting ready ...

Tennessee Gov. Bill Lee said the state had applied for a federal grant funding for rural healthcare, hoping for a piece of ...

A groundbreaking study is testing new ways to bring HIV prevention and PrEP to men whose work keeps them constantly on the road.

Recent analyst updates have led to a slight increase in Gilead Sciences’ fair value price target, moving from $127.23 to $129 ...

Introduction Saskatchewan is facing a public health crisis driven by high rates of HIV, syphilis and hepatitis C virus (HCV) infections, particularly among people who use drugs. Injection drug use is ...